For the quarter ending 2025-09-30, ISPC had $2,193,983 increase in cash & cash equivalents over the period. -$2,035,606 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Stock-based compensation expense | 1,797 | 17,704 |
| Bad debt expense | -3,521 | 17,578 |
| Accounts receivable | -255,059 | -1,054,589 |
| Prepaid expenses and other current assets | 493,196 | -59,966 |
| Operating lease right-of-use asset | 14,855 | 28,976 |
| Accounts payable | 456,016 | 117,449 |
| Accrued expenses | 71,311 | -523,219 |
| Deferred revenue | -8,560 | -196,642 |
| Depreciation of property and equipment | 17,123 | 34,228 |
| Amortization of internally developed software | 392,718 | 735,436 |
| Amortization of other intangible assets | 47,889 | 95,777 |
| Operating lease liability | -6,449 | -24,282 |
| Revenues from external customers | 106,592 | - |
| Cost of revenue, excluding amortization | 156,704 | - |
| Technology expenses, excluding amortization | 158,386 | - |
| Sales and marketing expenses | 1,140,902 | - |
| Supply development expenses | 22,373 | - |
| Fulfillment expenses | 153,781 | - |
| Other segment items | 799,722 | - |
| Depreciation & amortization expense | 457,730 | - |
| Interest expense | 2 | - |
| Interest income | 291 | - |
| Interest and penalties on sales tax liability | -2,069 | - |
| Net loss | -2,780,648 | -2,705,639 |
| Amortization of discount and debt issuance costs on senior note payable | 0 | - |
| Non-cash interest income related to accretion of discount on available-for-sale securities | 0 | 0 |
| Loss from sales of available-for-sale securities | 0 | 0 |
| Loss on disposal of property and equipment | 0 | - |
| Accounts receivable unbilled | 0 | 0 |
| Security deposit | 0 | - |
| Net cash used in operating activities | -2,035,606 | -1,288,079 |
| Purchase of property and equipment | 0 | 454 |
| Capitalization of internally developed software | 1,000,000 | 0 |
| Purchase of leasehold improvements included in operating lease right-of-use asset | 0 | - |
| Purchase of available-for-sale securities | 0 | 0 |
| Proceeds from sales and maturities of available-for-sale securities | 0 | 0 |
| Net cash provided by (used in) investing activities | -1,000,000 | -454 |
| Proceeds from issuance of common stock in connection with underwritten offering | 3,999,574 | - |
| Proceeds from issuance of common stock in connection with pipe offering | 1,751,098 | -1,100 |
| Payment of offering costs in connection with the completed financings | -521,083 | - |
| Repurchase of common stock purchase warrants exercisable under pipe warrants | - | 0 |
| Proceeds from issuance of senior note payable | 0 | - |
| Proceeds from issuance of common stock in connection with at the market offering agreement | 0 | 0 |
| Payment of debt issuance costs in connection with senior note payable | 0 | - |
| Payment of offering costs in connection with the issuance of common stock in connection with at the market offering agreement | 0 | 0 |
| Repurchase of common stock purchase warrants exercisable under pipe warrants | 0 | - |
| Net cash provided by financing activities | 5,229,589 | -1,100 |
| Net decreases in cash and cash equivalents | 2,193,983 | -1,289,633 |
| Cash and cash equivalents at beginning of period | 1,878,408 | - |
| Cash and cash equivalents at end of period | 2,782,758 | - |
iSpecimen Inc. (ISPC)
iSpecimen Inc. (ISPC)